Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications

[1]  Hideo Ayame,et al.  [The Da Qing IGT and Diabetes study]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[2]  W. Chick,et al.  Studies in the diabetic mutant mouse: III. Physiological factors associated with alterations in beta cell proliferation , 1970, Diabetologia.

[3]  W. Chick,et al.  Studies in the diabetic mutant mouse: II. Electron microscopy of pancreatic islets , 1970, Diabetologia.

[4]  D. Porte,et al.  Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance , 1987, Diabetologia.

[5]  C. Hellerström,et al.  The life story of the pancreatic B cell , 1984, Diabetologia.

[6]  B. Metcalf,et al.  Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. , 2003, Diabetes care.

[7]  R. LaPorte,et al.  Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. , 2003, Diabetes care.

[8]  M. Prentki,et al.  Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. , 2003, Endocrinology.

[9]  G. Sundkvist,et al.  Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. , 2003, Diabetes care.

[10]  Kathrin Maedler,et al.  Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes , 2003, Journal of Molecular Medicine.

[11]  L. Bouwens,et al.  Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. , 2003, Endocrinology.

[12]  V. Mooser,et al.  Insulin-secreting β-Cell Dysfunction Induced by Human Lipoproteins* , 2003, The Journal of Biological Chemistry.

[13]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[14]  T. Alexandrides,et al.  Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. , 2003, Diabetes.

[15]  James D. Johnson,et al.  Increased islet apoptosis in Pdx1+/- mice. , 2003, The Journal of clinical investigation.

[16]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[17]  P. Halban,et al.  Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.

[18]  D. Drucker.  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[19]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[20]  Yazhou Li,et al.  Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis* , 2003, The Journal of Biological Chemistry.

[21]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[22]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[23]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.

[24]  Masataka Mori,et al.  Endoplasmic reticulum stress and diabetes mellitus. , 2003, Internal medicine.

[25]  Yazhou Li,et al.  Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. , 2003, The Journal of biological chemistry.

[26]  V. Mooser,et al.  Insulin-secreting beta-cell dysfunction induced by human lipoproteins. , 2003, The Journal of biological chemistry.

[27]  In Kyu Lee,et al.  Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  L. Orci,et al.  Lipoapoptosis: its mechanism and its diseases. , 2002, Biochimica et biophysica acta.

[29]  D. Ron,et al.  Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.

[30]  N. Pørksen.  Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes. , 2002, Diabetes, nutrition & metabolism.

[31]  V. Grill,et al.  Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. , 2002, Diabetes & metabolism.

[32]  F. Ris,et al.  FLIP switches Fas-mediated glucose signaling in human pancreatic β cells from apoptosis to cell replication , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Finegood,et al.  β-Cell Neogenesis During Prolonged Hyperglycemia in Rats , 2002 .

[34]  L. Kuller,et al.  Is type 2 diabetes a chronic inflammatory/autoimmune disease? , 2002, Diabetes, nutrition & metabolism.

[35]  R. Robertson,et al.  Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.

[36]  D. Sgroi,et al.  Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. , 2002, Diabetes.

[37]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[38]  R. Robertson,et al.  Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. , 2002, Endocrinology.

[39]  D. Finegood,et al.  beta-cell neogenesis during prolonged hyperglycemia in rats. , 2002, Diabetes.

[40]  The Diabetes Prevention Program (DPP): description of lifestyle intervention. , 2002, Diabetes care.

[41]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[42]  N. Pørksen,et al.  The in vivo regulation of pulsatile insulin secretion , 2002, Diabetologia.

[43]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[44]  P. Halban,et al.  Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? , 2001, Diabetes.

[45]  M. Straume,et al.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.

[46]  M. Donath,et al.  Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. , 2001, Diabetes.

[47]  T. Wilkin.  The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes , 2001, Diabetologia.

[48]  G. Melino,et al.  High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. , 2001, Diabetes.

[49]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[50]  V. Grill,et al.  Overstimulation and beta-cell function. , 2001, Diabetes.

[51]  K. Maedler,et al.  Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. , 2001, Diabetes.

[52]  M G Kenward,et al.  Obesity, increased linear growth, and risk of type 1 diabetes in children. , 2000, Diabetes care.

[53]  S. Bonner-Weir.  Islet growth and development in the adult. , 2000, Journal of molecular endocrinology.

[54]  J. Habener,et al.  The adipoinsular axis: effects of leptin on pancreatic β-cells , 2000 .

[55]  L. Kuller,et al.  Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. , 2000, Diabetes.

[56]  J. Habener,et al.  The adipoinsular axis: effects of leptin on pancreatic beta-cells. , 2000, American journal of physiology. Endocrinology and metabolism.

[57]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[58]  S. Toyokuni,et al.  Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. , 1999, Diabetes.

[59]  B. Glaser,et al.  Early intensive insulin treatment for induction of long‐term glycaemic control in type 2 diabetes , 1999, Diabetes, obesity & metabolism.

[60]  S. Kahn,et al.  Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. , 1999, Diabetes.

[61]  B. Zhivotovsky,et al.  Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. , 1998, The Journal of biological chemistry.

[62]  M. A. Crook,et al.  Is Type II diabetes mellitus a disease of the innate immune system? , 1998, Diabetologia.

[63]  C. Newgard,et al.  Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[65]  C. Berne,et al.  Induction of β-Cell Rest in Type 1 Diabetes: Studies on the effects of octreotide and diazoxide , 1998, Diabetes Care.

[66]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[67]  R. Unger,et al.  Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Davoust,et al.  Processing of engulfed apoptotic bodies yields T cell epitopes. , 1997, Journal of immunology.

[69]  P. Halban,et al.  Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM , 1997, Diabetes.

[70]  B. Thorens,et al.  Inhibition of glucose‐induced insulin secretion by long‐term preexposure of pancreatic islets to leptin , 1997, FEBS letters.

[71]  D. Allan,et al.  Apoptosis Is the Mode of β-Cell Death Responsible for the Development of IDDM in the Nonobese Diabetic (NOD) Mouse , 1997, Diabetes.

[72]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[73]  D. Pipeleers,et al.  Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. , 1996, The Journal of clinical investigation.

[74]  P. Westermark.  Islet Pathology of Non‐insulin‐dependent Diabetes Mellitus (NIDDM) , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[75]  W. Soeller,et al.  Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R. Palmiter,et al.  Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[77]  J. Levy,et al.  U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.

[78]  G. Korbutt,et al.  Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. , 1992, The Journal of clinical investigation.

[79]  R. Bergman,et al.  Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. , 1992, The American journal of physiology.

[80]  E. Cerasi,et al.  Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. , 1991, Endocrinology.

[81]  G. Ward,et al.  Effects of Prolonged Pulsatile Hyperinsulinemia in Humans: Enhancement of Insulin Sensitivity , 1990, Diabetes.

[82]  J. Najarian,et al.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. , 1990, The New England journal of medicine.

[83]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[84]  K. Polonsky,et al.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[85]  J. Leahy,et al.  Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. , 1988, The Journal of clinical investigation.

[86]  J. Leahy,et al.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. , 1986, The Journal of clinical investigation.

[87]  J. Leahy,et al.  Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. , 1986, Diabetes/metabolism reviews.

[88]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.

[89]  J. Halter,et al.  Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus , 1984, Diabetes Care.

[90]  S. Bonner-Weir,et al.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.

[91]  C. Hales,et al.  IMPROVEMENT IN INSULIN SECRETION IN DIABETES AFTER DIAZOXIDE , 1976, The Lancet.

[92]  E. Cerasi,et al.  Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response? , 1967, Acta endocrinologica.

[93]  G. Grodsky,et al.  Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay , 1963, Diabetes.

[94]  S. Berson,et al.  Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay Technic , 1960, Diabetes.

[95]  R. Ogilvie,et al.  Quantitative Estimation of the Pancreatic Islet Tissue in Diabetic Subjects , 1955, Diabetes.

[96]  Dang Qing,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .